Beth Hecht, See Remarks at Xeris Biopharma Holdings, Inc. (XERS), sold 16,666 shares at $8.01 ($134K) on 2026-08-03, disclosed to the SEC on 2026-08-04.
Scheduled sale ($134k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| XERS | SELL | 2026-06-02 | $101K | — | Filing → |
| XERS | SELL | 2026-05-01 | $104K | — | Filing → |
| XERS | SELL | 2026-04-03 | $100K | — | Filing → |